Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients (TBIDU)

This study has been completed.
Sponsor:
Collaborators:
LLC Corrigo
Ida-Viru Central Hospital, Department of Tuberculosis
Information provided by:
National Institute for Health Development, Estonia
ClinicalTrials.gov Identifier:
NCT01290081
First received: February 3, 2011
Last updated: NA
Last verified: January 2008
History: No changes posted
  Purpose

The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.


Condition Intervention
Tuberculosis
Other: Case management approach in referral to health care services

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Prevalence of Latent Tuberculosis and Enhanced Tuberculosis Case Detection Among Injecting Drug Users Receiving Methadone Substitution Treatment

Resource links provided by NLM:


Further study details as provided by National Institute for Health Development, Estonia:

Enrollment: 112
Study Start Date: October 2007
Study Completion Date: January 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Active referral
Case management intervention group - study personnel scheduled the TB doctor appointment for the participant, reminded to keep it, and transportation to the clinic was organized when needed.
Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program
No Intervention: Passive referral
Participants were instructed to schedule an appointment with TB services themselves.
Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Participation in substitution treatment program,
  • Age 18 years or more,
  • Able to read and write in Estonian or Russian,
  • Able to provide informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01290081

Locations
Estonia
LLC Corrigo
Jõhvi, Ida-Virumaa, Estonia, 41532
Sponsors and Collaborators
National Institute for Health Development, Estonia
LLC Corrigo
Ida-Viru Central Hospital, Department of Tuberculosis
  More Information

No publications provided

Responsible Party: Kristi Rüütel, National Institute for Health Development
ClinicalTrials.gov Identifier: NCT01290081     History of Changes
Other Study ID Numbers: TBIDU-1230
Study First Received: February 3, 2011
Last Updated: February 3, 2011
Health Authority: Estonia: National Institute for Health Development

Keywords provided by National Institute for Health Development, Estonia:
Tuberculosis
Injecting drug users
Case management

Additional relevant MeSH terms:
Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on September 30, 2014